ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Wuxi Biologics (Cayman) Inc
4.60
-0.4750
-9.36%
成交量:
5,000.00
成交額:
2.30萬
市值:
190.33億
市盈率:
42.79
高:
4.60
開:
4.60
低:
4.60
收:
5.08
52周最高:
5.61
52周最低:
2.26
股本:
41.38億
流通股本:
37.33億
量比:
0.08
換手率:
0.00%
股息:
- -
股息率:
- -
每股收益(TTM):
0.1075
每股收益(LYR):
0.1126
淨資產收益率:
10.50%
總資產收益率:
5.89%
市淨率:
2.91
市盈率(LYR):
40.84
資料載入中...
總覽
公司
新聞資訊
公告
美國OTC市場藥明生物盤中異動 急速跳水7.56%報4.16美元
市场透视
·
2025/11/19
醫藥板塊回調與流感主題股逆勢上漲分析
新浪财经
·
2025/11/10
美國OTC市場藥明生物盤中異動 大幅跳水6.15%
市场透视
·
2025/10/22
創新藥License-out火爆,價值重估進行時
同壁财经
·
2025/10/22
醫療器械行業周報:假期港股表現較好 繼續看好Q3復甦趨勢
中信建投证券
·
2025/10/08
CXO,一定要出去搶!
谈思生物
·
2025/09/27
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/WXIBF/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"WXIBF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WXIBF\",,,,,undefined,":{"symbol":"WXIBF","market":"US","secType":"STK","nameCN":"Wuxi Biologics (Cayman) Inc","latestPrice":4.6,"timestamp":1773259200000,"preClose":5.075,"halted":0,"volume":5000,"delay":15,"changeRate":-0.0935960591133006,"floatShares":3732868601,"shares":4137541236,"eps":0.107499,"marketStatus":"未開盤","change":-0.475,"latestTime":"03-11 16:00:00 EDT 延時","open":4.6,"high":4.6,"low":4.6,"amount":23000,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.107499,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773302400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":5.075,"volumeRatio":0.081845},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WXIBF\",,,,,undefined,":{"symbol":"WXIBF","floatShares":3732868601,"roa":"5.89%","roe":"10.50%","lyrEps":0.112637,"volumeRatio":0.081845,"shares":4137541236,"dividePrice":0,"high":4.6,"amplitude":0,"preClose":5.075,"low":4.6,"week52Low":2.2566,"pbRate":"2.91","psRate":"6.53","week52High":5.606,"institutionHeld":0,"latestPrice":4.6,"eps":0.107499,"divideRate":0,"volume":5000,"delay":15,"ttmEps":0.107499,"open":4.6,"prevYearClose":4.22,"prevWeekClose":5.075,"prevMonthClose":5.075,"prevQuarterClose":4.22,"fiveDayClose":5.075,"twentyDayClose":5.2,"sixtyDayClose":4.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WXIBF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-17","symbol":"WXIBF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1660708800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2020-12-10","symbol":"WXIBF","type":"split","dateTimestamp":1607576400000,"forFactor":1,"toFactor":3,"ratio":0.333333},{"market":"US","date":"2020-11-16","symbol":"WXIBF","type":"split","dateTimestamp":1605502800000,"forFactor":1,"toFactor":3,"ratio":0.333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WXIBF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WXIBF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":25,"updateTime":1770782400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WXIBF\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584972045","title":"美國OTC市場藥明生物盤中異動 急速跳水7.56%報4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584972045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584972045?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 23:29","pubTimestamp":1763566140,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日23时29分,美国OTC市场药明生物股票出现异动,股价大幅下挫7.56%。截至发稿,该股报4.16美元/股,成交量840股,换手率0.00%,振幅0.00%。美国OTC市场药明生物股票所在的生物技术行业中,整体跌幅为0.25%。美国OTC市场药明生物公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119232901a704b14c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119232901a704b14c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","BK4121"],"gpt_icon":0},{"id":"2582879993","title":"醫藥板塊回調與流感主題股逆勢上漲分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879993","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879993?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776000,"startTime":"0","endTime":"0","summary":"在过去的两周中,医药板块面临一定的回调压力,主要指数普遍呈现震荡下跌的态势。尽管CXO板块的三季报业绩亮眼,但由于与创新药链条的密切关系,仍然出现了股价的下跌。这些与宏观经济状况相关的消极因素已经在医药板块的股价中得到了充分反映。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511102034379760415e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511102034379760415e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","IE00B0JY6N72.USD","LU0359202008.SGD","LU1794554557.SGD","LU0856984785.SGD","LU0823426480.USD","LU1688375341.USD","BK1515","LU0516422440.USD","BK1141","LU0348825331.USD","LU1880383366.USD","BK1161","LU3063872942.SGD","SG9999002562.SGD","LU0051755006.USD","LU1242518931.SGD","LU0320764599.SGD","06821","LU0819121731.USD","LU0823426308.USD","03347","LU0417516738.SGD","LU0181495838.USD","LU0326950275.SGD","LU0052750758.USD","LU0327786744.USD","LU0516422952.EUR","BK1589","LU0140636845.USD","LU0359201612.USD","BK1610","LU0456827905.SGD","LU0516422366.SGD","LU0516423091.SGD","LU0708995583.HKD","LU2039709279.SGD","LU1720050803.USD","LU0348735423.USD","09939","WXIBF","LU0572944931.SGD","BK1576","06160","LU0516423174.USD","02269","LU1242518857.USD","03759","LU0979878070.USD","LU0039217434.USD","LU0417516902.SGD","SG9999002463.SGD","BK1574","BK1521","LU0588546209.SGD","09995","LU0307460666.USD"],"gpt_icon":0},{"id":"2577434908","title":"美國OTC市場藥明生物盤中異動 大幅跳水6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577434908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577434908?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 22:52","pubTimestamp":1761144720,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日22时52分,美国OTC市场药明生物股票出现波动,股价急速下挫6.15%。美国OTC市场药明生物股票所在的生物技术行业中,整体跌幅为0.36%。美国OTC市场药明生物公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022225201a46ec888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022225201a46ec888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","BK4121"],"gpt_icon":0},{"id":"2577633992","title":"創新藥License-out火爆,價值重估進行時","url":"https://stock-news.laohu8.com/highlight/detail?id=2577633992","media":"同壁财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577633992?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 11:15","pubTimestamp":1761102906,"startTime":"0","endTime":"0","summary":"医药魔方数据显示,2025年上半年License-out交易达72笔,已超2024年全年总量的一半;交易总金额较2024年全年高出16%,其中单笔超10亿美元的交易共16笔。License-out同期首付款总额首次超过一级市场融资总额,成为Biotech企业资金回流的关键路径,BD出海正逐步成为Biotech不可或缺的“输血”渠道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022111705a46d83ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022111705a46d83ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","LU2242644610.SGD","02359","LU1046422090.SGD","LU2125910500.SGD","BK1583","LU0708995583.HKD","BK1576","06978","LU0320764599.SGD","BK1161","BK1141","BK1574","WXIBF","02269","LU2045819591.USD"],"gpt_icon":0},{"id":"2573923583","title":"醫療器械行業周報:假期港股表現較好 繼續看好Q3復甦趨勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2573923583","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573923583?lang=zh_tw&edition=fundamental","pubTime":"2025-10-08 00:00","pubTimestamp":1759852800,"startTime":"0","endTime":"0","summary":"其中微创医疗及部分子公司整体表现较好,预计与公告上海国资派驻董事参与董事会工作、治理改善和业绩修复预期相关;百心安和先健科技表现较好,预计与美国CMS有望将RDN纳入医保及TCT2025将公布铁基可降解支架最新数据等潜在事件催化有关。④关注中药、药店、流通、医疗服务及疫苗等行业经营触底回升节奏及长期转型升级方向。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510081826339723adab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510081826339723adab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["YANG","WXIBF","BK4121","BK4614"],"gpt_icon":0},{"id":"2570852976","title":"CXO,一定要出去搶!","url":"https://stock-news.laohu8.com/highlight/detail?id=2570852976","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570852976?lang=zh_tw&edition=fundamental","pubTime":"2025-09-27 11:00","pubTimestamp":1758942050,"startTime":"0","endTime":"0","summary":"既然药圈高处不胜寒,干脆换个赛道,蹲一蹲 CXO 的“洼地”。把视野放大,扫了眼国内 CXO 出海战绩,又对照了 Lonza 这类全球龙头,心里大概有了粗线条图景。如图,净利润同比飙升54.8%,增速相当惹眼。倘若把全球CXO的终局比作一条终点线,药明生物的赛程才跑到一半——Ⅲ期收入占比尚未过半,天花板还远在天边。微观来看,这是重写CXO世界版图;宏观而言,更是在撬动现有国际规则——只有把旧秩序撕开裂缝,中国产业链才算真正跨出国门。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927111944a6a165e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927111944a6a165e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1242518931.SGD","LU0417516902.SGD","LU0348825331.USD","LU0708995583.HKD","LU0823426308.USD","BK1589","BK1141","LU0140636845.USD","SG9999002562.SGD","LU0327786744.USD","LU0181495838.USD","LU1880383366.USD","LU1242518857.USD","LU0516422952.EUR","LU0516422440.USD","LU1688375341.USD","LU0043850808.USD","LU2039709279.SGD","IE00B0JY6N72.USD","LU0359202008.SGD","LU0359201612.USD","LU1720050803.USD","LU0456846285.SGD","LU0823426480.USD","LU0588546209.SGD","SG9999002463.SGD","BK1576","LU0326950275.SGD","LU0516422366.SGD","LU0039217434.USD","LU0819121731.USD","LU1794554557.SGD","LU0307460666.USD","LU0417516738.SGD","LU0572944931.SGD","LU0052750758.USD","WXIBF","LU0320764599.SGD","02269","LU0051755006.USD","LU0456827905.SGD","LU0348735423.USD","LU0856984785.SGD","LU0516423091.SGD","LU0979878070.USD","BK1521","BK1610","LU0516423174.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}